SCHEMBL16357336

SCHEMBL16357336

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5ccn(-c6ccccc6)c5ccc43)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 4/20 0.34
▸ CYP11B1 P15538 2/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ POLB P06746 2/20 0.32
▸ CTDSP1 Q9GZU7 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ ACHE P22303 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ PTGER1 P34995 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15801901 0.96 KDM4E (0.33) CYP19A1CYP11B1CYP17A1KDM4EL3MBTL1
SCHEMBL15632164 0.93 KDM4E (0.36) KDM4EL3MBTL1ATMPOLBCTDSP1
SCHEMBL15801933 0.91 KDM4E (0.32) KDM4EL3MBTL1ATM
SCHEMBL15632179 0.91 KDM4E (0.36) CYP19A1CYP11B1CYP17A1KDM4EL3MBTL1
SCHEMBL20426182 0.91 L3MBTL1 (0.39) CYP19A1CYP11B1CYP17A1KDM4EL3MBTL1
SCHEMBL15632104 0.87 CYP19A1 (0.33) CYP19A1CYP11B1CYP17A1KDM4EL3MBTL1
SCHEMBL15801476 0.87 KDM4E (0.31) CYP19A1CYP11B1CYP17A1KDM4EL3MBTL1
SCHEMBL15073582 0.87 L3MBTL1 (0.41) CYP19A1KDM4EL3MBTL1ATMPOLB
SCHEMBL15802355 0.87 KDM4E (0.33) KDM4EL3MBTL1ATM
SCHEMBL2754622 0.87 L3MBTL1 (0.44) CYP19A1KDM4EL3MBTL1ATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU CYP19A1 870/4885CYP11B1 949/4885CYP17A1 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback